0QJS.LSE Clariant AG
- Market cap
- GBP 5.87B
- P/E
- 17.1x
- P/B
- -
- ROE
- 13.9%
- Dividend yield
- 0.05%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is 0QJS.LSE undervalued?
Graham numberThe Graham number of Clariant AG cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Clariant AG fundamental analysis
No fundamental analysis for Clariant AG yet.
Clariant AG stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Clariant AG
Clariant AG develops, manufactures, distributes, and sells specialty chemicals in Switzerland, Europe, the Middle East, Africa, the United States, and the Asia Pacific. It operates through Care Chemicals, Catalysts, and Adsorbents & Additives segments. The Care Chemicals segment offers personal and home care, crop solutions, industrial applications, base chemicals, oil services, and mining solutions for various applications in home and personal care, coatings, adhesives, and…
Full company profileClariant AG financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Clariant AG annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 5.85B | 6.38B | 6.62B | 4.40B | 3.86B | 4.37B | 5.20B | 4.38B | 4.15B | 3.92B | 7.44B |
| Gross Profit | 1.77B | 1.90B | 1.93B | 1.38B | 1.17B | 1.30B | 1.03B | 1.20B | 1.26B | 1.22B | 2.36B |
| Operating Income | 512M | 496M | 546M | 165M | 298M | 440M | 72.0M | 282M | 440M | 398M | 783M |
| EBITDA | 780M | 853M | 667M | 497M | 571M | 723M | 337M | 510M | 696M | 650M | 1.25B |
| Net Income | 253M | 277M | 337M | -34.0M | 116M | 344M | -101M | 134M | 244M | -75.0M | 281M |
| EPS | 0.78 | 0.84 | 1.02 | -0.10 | 0.35 | 1.04 | -0.31 | 0.41 | 0.74 | -0.23 | 0.85 |
| Balance Sheet | |||||||||||
| Total Assets | 8.37B | 8.23B | 7.98B | 7.98B | 6.93B | 7.04B | 6.19B | 5.35B | 6.26B | 5.87B | 6.05B |
| Total Liabilities | 5.82B | 5.29B | 5.01B | 5.30B | 4.55B | 4.49B | 3.68B | 3.17B | 3.76B | 3.69B | 3.87B |
| Shareholders' Equity | 2.46B | 2.76B | 2.80B | 2.51B | 2.24B | 2.36B | 2.34B | 2.02B | 2.34B | 2.02B | 2.02B |
| Cash & Short-term Investments | 1.37B | 748M | 925M | 1.01B | 1.06B | 476M | 758M | 593M | 471M | 617M | 634M |
| Total Debt | 2.87B | 2.29B | 2.24B | 2.29B | 2.02B | 1.95B | 1.46B | 1.35B | 1.88B | 2.16B | 2.13B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 646M | 428M | 530M | 509M | 369M | 363M | 502M | 424M | 418M | 379M | 576M |
| Capital Expenditure | 336M | 279M | 257M | 272M | 299M | 357M | 208M | 207M | 209M | 145M | 176M |
| Free Cash Flow | 310M | 149M | 273M | 237M | 70.0M | 6.00M | 294M | 214M | 209M | 234M | 400M |
| Ratios | |||||||||||
| ROE | 10.3% | 10.0% | 12.0% | -1.4% | 5.2% | 14.6% | -4.3% | 6.6% | 10.4% | -3.7% | 13.9% |
| ROA | 3.0% | 3.4% | 4.2% | -0.4% | 1.7% | 4.9% | -1.6% | 2.5% | 3.9% | -1.3% | 4.6% |
| Net Profit Margin | 4.3% | 4.3% | 5.1% | -0.8% | 3.0% | 7.9% | -1.9% | 3.1% | 5.9% | -1.9% | 3.8% |
| Debt to Equity | 1.16x | 0.83x | 0.80x | 0.91x | 0.90x | 0.83x | 0.63x | 0.67x | 0.81x | 1.07x | 1.05x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Clariant AG dividends
- Dividend yield
- 0.05%
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | 138M | 0.42 | - |
| 2024 | CHF 139M | 0.42 | 57.0% |
| 2023 | CHF 138M | 0.42 | 103.0% |
| 2022 | GBP 132M | 0.40 | - |
| 2021 | GBP 230M | 0.69 | 66.9% |
| 2020 | GBP 989M | 2.99 | 852.6% |
| 2019 | GBP 181M | 0.55 | - |
| 2018 | GBP 165M | 0.50 | 49.0% |
| 2017 | GBP 148M | 0.45 | 53.4% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 3773:3750 on Apr 11, 2011.
Who owns Clariant AG
- Insiders 5.36%
- Institutions 55.26%
- Public & others 39.38%
- Shares outstanding 330M
- Free float 195M
Clariant AG company profile
- Company name
- Clariant AG
- Ticker
- 0QJS.LSE
- ISIN
- CH0012142631
- Exchange
- London Exchange
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 10,107
- Fiscal year end
- December
- Address
- Rothausstrasse 61, Muttenz, Switzerland, 4132
- Phone
- 41 61 469 51 11
- Website
- clariant.com
About Clariant AG
Clariant AG develops, manufactures, distributes, and sells specialty chemicals in Switzerland, Europe, the Middle East, Africa, the United States, and the Asia Pacific. It operates through Care Chemicals, Catalysts, and Adsorbents & Additives segments. The Care Chemicals segment offers personal and home care, crop solutions, industrial applications, base chemicals, oil services, and mining solutions for various applications in home and personal care, coatings, adhesives, and agriculture, and food. The Catalysis segment provides business services for propylene and ethylene, syngas and fuels, and specialties. The Adsorbents & Additives segment provides coatings, adhesives and polymer solutions for home care, personal care, coatings, adhesives, agriculture, food, electrics, electronics, automotive, oil, building, construction, aviation, and mining. The company was founded in 1886 and is headquartered in Muttenz, Switzerland.
Clariant AG management
10- Mr. Conrad KeijzerChief Executive Officer · born 1968
- Mr. Oliver RittgenChief Financial Officer
- Mr. Richard Haldimann Ph.D.Chief Strategy & Technology Officer
- Mr. Andreas SchwarzwaelderHead of Investor Relations
- Dr. Judith BischoffGeneral Counsel & Head of Group Legal Services · born 1974
- Kai RolkerHead of Group Communications
- Priya ThamanChief Human Resources Officer
- Mr. Joachim KrügerHead of Corporate Sustainability & Regulatory Affairs
- Monica FerreiraRegion Head of Latin America
- Mr. Christian VangPresident of BU Care Chemicals & Americas Region